Anti-TIGIT antibodies and methods of use
Abstract:
Antibodies and antigen-binding fragments that bind to TIGIT are disclosed. The disclosure further relates to methods and compositions for use in treating an immune-related disease (e.g., a cancer or an infection or infectious disease) by administering a composition disclosed herein.
Public/Granted literature
Information query
Patent Agency Ranking
0/0